The Food and Drugs Authority (FDA) has taken decisive action against Aveo Pharmaceuticals, an Indian drug manufacturer, following revelations of its role in smuggling unapproved opioid-based medications into West Africa. The regulatory body has suspended the company’s Good Manufacturing Practices (GMP) certification and placed restrictions on local pharmaceutical firms linked to its supply chain. As […]